Quibim Company Profile: Funding, Investors & Partnerships

Quibim

Quibim plans to become the global leader in virtual biopsies, using quantitative imaging biomarkers to unlock complex diseases signals in medical images.Clinicians, researchers and pharmaceutical companies use Quibim Precision®, an ecosystem of radiological medical image analysis applications, to assess every part of the body and in different clinical scenarios, from disease detection to monitoring the efficacy of new treatments.Quibim plans to become the global leader in virtual biopsies, using quantitative imaging biomarkers Show More

Alpha Score

69.1

Total Funding$ 131.66 M